Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Bifidobacterium eulemuris - : Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus {Bio-three} |
👶
Does probiotics administration decrease serum endotoxin levels in infants? Journal of pediatric surgery (J Pediatr Surg ) Vol: 34 Issue 2 Pages: 273-6 Pub: 1999 Feb Epub: Authors Urao M , Fujimoto T , Lane GJ , Seo G , Miyano T , Publication |
| Increases Bifidobacterium eulemuris - : Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus {Bio-three} |
👶
Probiotics have clinical, microbiologic, and immunologic efficacy in acute infectious diarrhea. The Pediatric infectious disease journal (Pediatr Infect Dis J ) Vol: 29 Issue 2 Pages: 135-8 Pub: 2010 Feb Epub: Authors Chen CC , Kong MS , Lai MW , Chao HC , Chang KW , Chen SY , Huang YC , Chiu CH , Li WC , Lin PY , Chen CJ , Li TY , Publication |
| Increases Bifidobacterium eulemuris - : Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus {Bio-three} |
👶
The antioxidant strain Lactiplantibacillus plantarum AS21 and Clostridium butyricum ameliorate DSS-induced colitis in mice by remodeling the assembly of intestinal microbiota and improving gut functions. Food & function (Food Funct ) Vol: 15 Issue 4 Pages: 2022-2037 Pub: 2024 Feb 19 Epub: 2024 Feb 19 Authors Li W , Zhang Y , Chen M , Guo X , Ding Z , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
